Two NHS staff 'recovering well' after allergic reaction to Covid vaccine

9 December 2020, 09:50 | Updated: 9 December 2020, 18:07

A Pfizer-BioNTech COVID-19 vaccine is prepared at the Royal Victoria Infirmary in Newcastle
A Pfizer-BioNTech COVID-19 vaccine is prepared at the Royal Victoria Infirmary in Newcastle. Picture: PA

By Megan White

Two NHS staff members who received the Pfizer/BioNTech vaccine on Tuesday - the first day of the mass vaccination programme - are recovering well after suffering an allergic reaction.

It is understood that both the staff members had a significant history of allergic reactions - to the extent where they need to carry an adrenaline auto injector with them.

They developed symptoms of "anaphylactoid reaction" shortly after receiving the vaccine and both have recovered after the appropriate treatment.

Following the incident, regulators issued a warning that people who have a history of "significant" allergic reactions should not currently receive the jab following the incident.

Read more: Covid vaccine: GP's advice for people with allergies

Read more: Who can't have the Covid-19 vaccine and why?

The NHS in England said all trusts involved with the vaccination programme have been informed.

Professor Stephen Powis, national medical director for the NHS in England, said: "As is common with new vaccines the MHRA have advised on a precautionary basis that people with a significant history of allergic reactions do not receive this vaccination after two people with a history of significant allergic reactions responded adversely yesterday. Both are recovering well."

The Medicines and Healthcare products Regulatory Agency (MHRA) has given precautionary advice to NHS trusts that anyone who has a history of "significant" allergic reactions to medicines, food or vaccines should not receive the vaccine.

Read more: Poorer countries risk being left behind in Covid-19 vaccine rollout, campaigners warn

Nick Ferrari speaks to Prof Steve Powis as Covid vaccine is rolled out

This means that anyone scheduled to receive the vaccine on Wednesday will be asked about their history of allergic reactions.

The MHRA advice states: "Any person with a history of a significant allergic reaction to a vaccine, medicine or food (such as previous history of anaphylactoid reaction or those who have been advised to carry an adrenaline autoinjector) should not receive the Pfizer/BioNtech vaccine.

"Resuscitation facilities should be available at all times for all vaccinations. Vaccination should only be carried out in facilities where resuscitation measures are available."

Dr June Raine, chief executive of the Medicines and Healthcare products Regulatory Agency (MHRA), said that careful plans had been made for "real-time vigilance" when monitoring side effects from vaccinations and that any updates to advice for patients would be communicated "immediately".

She told the Commons Science and Technology Committee that regulators had been aware since Tuesday night that two people who had received the vaccination had experienced allergic reactions.

"The role is before, during and after, and there is a true end-to-end looking from the scientific laboratory bench through to the patient who yesterday first received the vaccine," she said.

Terminally ill man says he 'hasn't been considered' a vaccine priority

"As an illustration to this, I may share with the committee that even last evening we were looking at two case reports of allergic reaction.

"We know from the very extensive clinical trials that this wasn't a feature but if we need to strengthen our advice now that we have had this experience in the vulnerable populations ... we will get that advice to the field immediately."

Pfizer said the vaccine was "well tolerated" during the trials with "no serious safety concerns".

A spokeswoman said: "We have been advised by MHRA of two yellow card reports that may be associated with allergic reaction due to administration of the Covid-19 BNT162b2 vaccine.

"As a precautionary measure, the MHRA has issued temporary guidance to the NHS while it conducts an investigation in order to fully understand each case and its causes. Pfizer and BioNTech are supporting the MHRA in the investigation.

"In the pivotal phase three clinical trial, this vaccine was generally well tolerated with no serious safety concerns reported by the independent Data Monitoring Committee. The trial has enrolled over 44,000 participants to date, over 42,000 of whom have received a second vaccination."

More Latest News

See more More Latest News

Palestinian crowds struggle to buy bread from a bakery in Rafah, Gaza Strip

UN World Food Programme suspends aid amid chaos in northern Gaza

The Security Council meets before voting on a resolution concerning a ceasefire in Gaza at United Nations headquarters

US vetoes UN resolution demanding immediate humanitarian ceasefire in Gaza

Duane 'Keffe D' Davis in court during a status hearing at the Regional Justice Centre in Las Vegas

Ex-gang leader’s murder trial over Tupac Shakur killing pushed back to November

Under the order, Lingham is banned from entering Holt Lowes between February 1 and October 1.

Shell-shocked: 'Addicted' Norfolk man illegally collected 3,000 native bird eggs

Defendant Ruby Franke looks on during court in St George, Utah

YouTuber Ruby Franke apologises at sentencing in child abuse case

In an apparent attempt to get ahead of another possible rebellion, Labour on Tuesday tabled its lengthy amendment, which will be voted on tomorrow.

'I want to do what is right': Labour's ceasefire motion is 'broader' and 'goes further' than the SNP's, says David Lammy

Prince William has called for an end to the Israel-Hamas war

Israel says Gaza war will only end when 'Hamas is dismantled' in direct reply to Prince William’s intervention

David Neal has been sacked by the Home Office

Home Office fires immigration chief inspector David Neal after claims about security risks at major London airport

Exclusive
Shahd Waleed is trying to leave Rafah with her parents and enter Egypt

'They want us to experience pain': Young woman trapped in Rafah with her parents tells of terror as Israel invasion looms

Gabriela was fired from her job cleaning at Devonshires

Cleaner ‘fired after taking leftover £1.50 tuna sandwich’ speaks out against ‘unfair bosses’ as protesters target law firm

Before this announcement, Tesco only showed unit pricing on normal prices and not their special Clubcard prices.

Tesco announce big change to how it displays Clubcard prices - and it could save you money

Russian defector Maksim Kuzminov at a press conference in Kyiv, Ukraine, in September 2023

Spanish police suspect bullet-riddled body may be that of Russian who defected

Russia Ukraine War Putin’s Game

Zelensky says Russia ‘taking advantage’ of delays in assistance to Ukraine

Kristina Rihanoff claims Robin Windsor was in ‘excruciating pain’ before his sudden death

'May you dance with the angels': Robin Windsor's Strictly partner says dancer was in ‘excruciating pain’ before death

A man walks along the Naviglio Pavese canal shrouded in mist and smog in Milan, Italy

Milan imposes anti-smog measures during bout of bad air pollution

28-year-old Valeria Amorim was pronounced dead at the scene.

Pregnant woman killed after car crashes into group of people